Close Menu

NEW YORK – Swift Biosciences announced on Monday it will exclusively distribute BillionToOne's test kit for detecting SARS-CoV-2. 

The qSanger-COVID-19 assay, which received Emergency Use Authorization from the US Food and Drug Administration earlier this month, detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day, according to Swift Biosciences. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.